Henry Schein (HSIC) Expected to Announce Quarterly Earnings on Monday

Henry Schein (NASDAQ:HSIC - Get Free Report) is projected to issue its Q1 2025 quarterly earnings data before the market opens on Monday, May 5th. Analysts expect the company to announce earnings of $1.11 per share and revenue of $3.24 billion for the quarter. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS and its FY25 guidance at $4.80-4.94 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same period last year, the firm earned $0.66 EPS. The company's revenue for the quarter was up 5.8% compared to the same quarter last year. On average, analysts expect Henry Schein to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Henry Schein Trading Down 1.6 %

Shares of HSIC opened at $65.17 on Monday. Henry Schein has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm's fifty day moving average is $69.21 and its two-hundred day moving average is $71.80. The stock has a market cap of $7.98 billion, a PE ratio of 26.82, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84.

Wall Street Analysts Forecast Growth

HSIC has been the topic of several recent research reports. Jefferies Financial Group lifted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Barrington Research reaffirmed an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. StockNews.com lowered Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and lifted their price target for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target on the stock. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $81.10.

Insider Activity at Henry Schein

In related news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.